365
Views
93
CrossRef citations to date
0
Altmetric
Original Articles

Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells

, , , , , & show all
Pages 1290-1299 | Received 18 Jan 2017, Accepted 26 Jun 2017, Published online: 30 Oct 2017

References

  • Ciombor K, Wu C, and Goldberg R: Recent therapeutic advances in the treatment of colorectal cancer. Ann Rev Med 66, 83–95, 2015.
  • Ricciardiello L, Bazzoli F, and Fogliano V: Phytochemicals and colorectal cancer prevention—myth or reality? Nat Rev Gastroenterol Hepatol 8(10), 592–596, 2011.
  • Farajzadeh R, et al.: Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif Cells Nanomed Biotechnol 1–9, 2017.
  • Maasomi ZJ, Soltanahmadi YP, Dadashpour M, Alipour S, Abolhasani S, Zarghami N: Synergistic anticancer effects of silibinin and chrysin in T47D breast cancer cells. Asian Pac J Cancer Prev 18(5), 1283–1287, 2017.
  • Valencia P, et al.: Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles. Nanomedicine 8(5), 687–698, 2013.
  • Alibakhshi A, et al.: An update on phytochemicals substances in molecular target therapy of cancer: potential inhibitory effect on telomerase activity. Curr Med Chem 23(22), 2380–2393, 2016.
  • Montazeri M, et al.: Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. Int J Pharm 509(1), 244–254, 2016.
  • Singh A, et al.: Emerging importance of dietary phytochemicals in fight against cancer: role in targeting cancer stem cells. Crit Rev Food Sci Nutr 57(16), 3449–3463, 2016.
  • Kazemi-Lomedasht F, Rami A, and Zarghami N: Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv Pharm Bull 3(1), 127–130, 2013.
  • Badrzadeh F, et al.: Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac J Cancer Prev 15(20), 8931–8936, 2014.
  • Bill M, et al.: Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther 8(9), 2726–2735, 2009.
  • Park W, et al.: New perspectives of curcumin in cancer prevention. Cancer Prev Res 6(5), 387–400, 2013.
  • Shakibaei M, et al.: Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PloS One 8(2), e57218, 2013.
  • Mohammadian F, et al.: Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line. Iran J Cancer Prev 9(4), 2016.
  • Mohammadian F, et al.: Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artif Cells, Nanomedicine, Biotechnol 1–6, 2016.
  • Mohammadian F, et al.: Upregulation of Mir-34a in AGS gastric cancer cells by a PLGA-PEG-PLGA chrysin nano formulation. Asian Pac J Cancer Prev 16(18), 8259–8263, 2015.
  • Mohammadian F, et al.: Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles. Artif Cells, Nanomedicine, Biotechnol 1–7, 2016.
  • Mohammadinejad S, et al.: Preparation and evaluation of chrysin encapsulated in PLGA-PEG nanoparticles in the T47-D breast cancer cell line. Asian Pac J Cancer Prev: APJCP 16(9), 3753–3758, 2014.
  • Khoo B, Chua S, and Balaram P: Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci 11(5), 2188–2199, 2010.
  • Kasala E, et al.: Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicol Lett 233(2), 214–225, 2015.
  • Anari E, Akbarzadeh A, and Zarghami N: Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells, Nanomedicine, Biotechnol 1–7, 2015.
  • Jung J: Emerging utilization of chrysin using nanoscale modification. J Nanomaterials 2016, 2016.
  • Tabatabaei Mirakabad F, et al.: A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells, Nanomedicine, Biotechnol 44(1), 423–430, 2016.
  • Kamaly N, et al.: Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev 116(4), 2602–2663, 2016.
  • Eatemadi A, et al.: Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines. Artif Cells, Nanomedicine, Biotechnol 44(3), 1008–1017, 2016.
  • Feng S-S: New-concept chemotherapy by nanoparticles of biodegradable polymers: Where are we now?. Nanomedicine, 1(3), 297–309, 2006.
  • Danhier F, et al.: PLGA-based nanoparticles: an overview of biomedical applications. J Contro Release 161(2), 505–522, 2012.
  • Xiao B, et al.: Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. J Mater Chem B, Mater Biol Med 3(39), 7724–7733, 2015.
  • Aslan B, et al.: Nanotechnology in cancer therapy. J Drug Target 21(10), 904–913, 2013.
  • Chou T-C: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70(2), 440–446, 2010.
  • Rahmati-Yamchi M, et al.: Plasma leptin, hTERT gene expression, and anthropometric measures in obese and non-obese women with breast cancer. Breast Cancer: Basic Clin Res 5, 27–35, 2011.
  • Montazeri M, et al.: Antiproliferative and apoptotic effect of dendrosomal curcumin nanoformulation in P53 mutant and wide-type cancer cell lines. Anti-Cancer Agents Med Chem 2016.
  • Hasima N and Aggarwal B B: Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment. Curr Med Chem 21(14), 1583–1594, 2014.
  • Woo K, et al.: Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun 325(4), 1215–1222, 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.